[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635407":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":10,"centralContacts":30,"locations":36,"responsibleParty":54,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":58,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":68,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"The First Affiliated Hospital of Soochow University","OTHER",[8,13,16,19,22],{"label":9,"type":10,"description":10,"interventionNames":11},"the categorie is GG1 according to the ISUP grading standard",null,[12],"Other: observational study",{"label":14,"type":10,"description":10,"interventionNames":15},"the categorie is GG2 according to the ISUP grading standard",[12],{"label":17,"type":10,"description":10,"interventionNames":18},"the categorie is GG3 according to the ISUP grading standard",[12],{"label":20,"type":10,"description":10,"interventionNames":21},"the categorie is GG4 according to the ISUP grading standard",[12],{"label":23,"type":10,"description":10,"interventionNames":24},"the categorie is GG5 according to the ISUP grading standard",[12],[26],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":10},"observational study","The researchers will conduct observations, collect data and conduct follow-ups on the participants, but will not actively alter their treatment or health conditions.",[9,14,17,20,23],[31],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},"Qian Zhang","CONTACT","+86 15137562688","zhangqian0194@163.com",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":10,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Suzhou","Jiangsu","China","CN",{"type":44,"coordinates":45},"Point",[46,47],120.59538,31.30408,{"lat":47,"lon":46},[50],{"name":51,"role":33,"phone":52,"phoneExt":10,"email":53},"Gang Chen","+86 0512 67972861","E-mail:sdfyec@163.com",{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100635407","the-enhancement-of-diagnostic-and-grading-efficacy-of-prostate-cancer-by-new-mri-sequences-a-prospective-observational-study-based-on-new-mri-sequences-in-a-single-center-100635407",false,"NCT07552285","The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center","Inclusion Criteria:\n\n1. Patients with a high clinical suspicion of prostate cancer and elevated tPSA levels;\n2. Patients with no prior history of other tumors;\n3. Patients with no contraindications to MRI, including claustrophobia, presence of pacemakers, cardiac stents, or metal implants such as screws and plates.\n\nExclusion Criteria:\n\n1. The patient has a history of malignant tumors and has received corresponding treatment;\n2. Prior to the MRI examination, the patient has undergone treatment for prostate cancer, including endocrine therapy, radiotherapy, etc.;\n3. Patients who have previously undergone radical prostatectomy for prostate cancer.","MALE","20 Years","90 Years",{"count":66,"type":67},300,"ESTIMATED","4 Months","OBSERVATIONAL","The goal of this clinical trial aims to explore the diagnostic efficacy and grading of prostate cancer by a novel MRI sequences such as MAGiC，OGSE,CEST,IVIM,etc.The main question it aims to answer is:\n\nCan the novel non-contrast multiparametric MRI imaging improve the accuracy of diagnosis and grading of prostate cancer? For patients with clinical suspicion of prostate cancer, both conventional and new sequences magnetic resonance scans are conducted, with surgical or biopsy pathological results serving as the gold standard.",[72,73],"Prostate Cancer","Prostate Cancer (Diagnosis)","2026-04-20",{"date":76,"type":77},"2026-04-27","ACTUAL",{"date":79,"type":77},"2025-05-01",{"date":81,"type":67},"2027-06-01",{"name":5,"class":6},1]